Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
Terns Pharmaceuticals, Inc. announced participation in upcoming investor conferences in March to discuss their small-molecule product candidates for serious diseases like oncology and obesity. The events include TD Cowen 44th Annual Health Care Conference and Inaugural BMO Obesity Summit, with live webcasts available on the company's investor relations page.
02/27/2024 - 04:05 PM
FOSTER CITY, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that members of senior management will be participating in the following upcoming investor conferences in March.
TD Cowen 44 th Annual Health Care Conference Date/Time: Monday, March 4, 2024 at 12:50 p.m. ET Format: Panel Presentation Location: Boston, MA
Inaugural BMO Obesity Summit Date/Time: Wednesday, March 20, 2024 at 11:00 a.m. ET Format: Company Presentation Location: New York, NY
Live webcasts of the events will be available on the investor relations page of Terns’ website at http://ir.ternspharma.com . A replay of the webcasts will be archived on Terns’ website for at least 30 days following the presentations.
About Terns Pharmaceuticals Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, and a THR-β agonist, and a preclinical GIPR modulator program. For more information, please visit: www.ternspharma.com .
Contacts for Terns
Investors Justin Nginvestors@ternspharma.com
Media Jenna Urban Berry & Company Public Relationsmedia@ternspharma.com
When is Terns Pharmaceuticals participating in the TD Cowen 44th Annual Health Care Conference?
Terns Pharmaceuticals is participating in the TD Cowen 44th Annual Health Care Conference on Monday, March 4, 2024, at 12:50 p.m. ET.
Where will the Inaugural BMO Obesity Summit take place?
The Inaugural BMO Obesity Summit will take place in New York, NY on Wednesday, March 20, 2024, at 11:00 a.m. ET.
Where can investors watch the live webcasts of the events?
Investors can watch the live webcasts of the events on Terns Pharmaceuticals' investor relations page at http://ir.ternspharma.com.
How long will the replay of the webcasts be available on Terns' website?
The replay of the webcasts will be archived on Terns' website for at least 30 days following the presentations.
Terns Pharmaceuticals Inc
TERN Rankings
#3703 Ranked by Stock Gains
TERN Stock Data
Industry
Medicinal and Botanical Manufacturing
Sector
Manufacturing
About TERN
terns pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver diseases and cancers. the company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in china to advance its growing pipeline of drugs that are optimized against clinically-validated targets. based in san mateo, california and shanghai, terns is focused on bringing forward innovative therapeutic candidates with the potential to address significant unmet medical needs in china and globally.